tirzepatide press release Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Keeping weight off after losing

The 2024 prescribing data shows over 8 million Americans on a GLP-1, most self-injecting weekly

For patients who experience facial volume changes or skin laxity during their weight loss, we offer in-office restoration RF microneedling, biostimulators, targeted facial treatments supervised by the same physician who knows your history

Based on studies suggesting people taking a glucagon-like peptide-1 (GLP-1) could be less likely to develop Alzheimers, Novo Nordisk set up two large trials of its drug, semaglutide sold as the popular diabetes and obesity drugs Ozempic and Wegovy

Healthcare providers may sometimes recommend: alternative GLP-1 medications adjusting dose schedules temporary medication substitutions These decisions should always be made with guidance from a healthcare professional

Skin and connective-tissue effects build over 4 to 12 weeks of consistent use

Contact us at The Sculptique Aesthetics